Latest News in the pharma Industry

Research & Development

Oxford Genetics secures £1.61m grant to establish next-generation bioproduction technologies

Oxford Genetics secures £1.61m grant to establish next-generation bioproduction technologies

15 Dec 2016

The project aims to create a step-change in the capabilities of current bioproduction methods, meeting unmet needs in the field of viral vector production.

Read more 
Catalent Biologics to collaborate with PATH Malaria Vaccine Initiative

Catalent Biologics to collaborate with PATH Malaria Vaccine Initiative

15 Dec 2016

Catalent Biologics will employ its proprietary GPEx cell line technology and ambr workstation to develop, optimize the process for expression, and manufacture antibodies for further investigation by MVI and its partners.

Read more 
Pfizer's acquired Xtandi fails to meet its primary endpoint in study

Pfizer's acquired Xtandi fails to meet its primary endpoint in study

15 Dec 2016

Phase IV study demonstrates a lack of improvement in progression-free survival in patients with chemotherapy-naïve metastatic CRPC whose prostate-specific antigen has previously progressed on Xtandi.

Read more 
Acousia Therapeutics receives EUR 2.5 M to develop innovative therapy to treat and prevent sensorineural hearing loss

Acousia Therapeutics receives EUR 2.5 M to develop innovative therapy to treat and prevent sensorineural hearing loss

14 Dec 2016

New shareholder, Axxamof Milan, Italy, will transfer certain therapeutic assets to the R&D programs of Acousia.

Read more 
Lilly and AstraZeneca to develop second potentially disease-modifying treatment for Alzheimer's

Lilly and AstraZeneca to develop second potentially disease-modifying treatment for Alzheimer's

10 Dec 2016

"MEDI1814 has a unique mechanism among antibodies in clinical development and could provide a distinct approach to treating Alzheimer's disease."

Read more 
Albumedix and NYU School of Medicine to investigate targeting novel cellular pathways in oncology

Albumedix and NYU School of Medicine to investigate targeting novel cellular pathways in oncology

6 Dec 2016

Collaboration will explore the potential of novel applications of Albumedix’s albumin-based drug delivery platform, Veltis.

Read more 
Saneca to drive R&D initiative following €1.5 million funding

Saneca to drive R&D initiative following €1.5 million funding

5 Dec 2016

The CDMO’s initiatives include laboratory research for the preparation of APIs, with a particular focus on chiral molecules and emphasis on the principles of sustainable development and ‘green chemistry’.

Read more 
Interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product

Interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product

5 Dec 2016

If approved, the product could provide blood cancer patients with access to potentially life-saving medicine.

Read more 
Novel nanoscale vehicles for drug delivery

Novel nanoscale vehicles for drug delivery

5 Dec 2016

UCL pioneers the engineering of novel nanoscale drug delivery vehicles, which can be tuned to release a range of cargos.

Read more 
FDA approves Jardiance tablets to reduce the risk of cardiovascular death in adults with T2D

FDA approves Jardiance tablets to reduce the risk of cardiovascular death in adults with T2D

5 Dec 2016

The only oral T2D medicine to provide a life-saving cardiovascular benefit.

Read more 
Novartis SEG101 significantly reduces frequency of sickle cell pain crises in Phase II study

Novartis SEG101 significantly reduces frequency of sickle cell pain crises in Phase II study

4 Dec 2016

Represents a potentially novel disease-modifying therapeutic option.

Read more 
CSL commits to new Phase I clinical trials in Australia

CSL commits to new Phase I clinical trials in Australia

3 Dec 2016

Read more